Uncategorised Archives - Page 11 of 19

Acute Kidney Injury Market: Epidemiology, Therapies, Companies, DelveInsight

Acute Kidney Injury Market, DelveInsight Acute Kidney Injury therapies such as RBT-1, OCE-205, and other emerging candidates are anticipated to contribute significantly to the expansion of the Acute Kidney Injury Market in the coming years. DelveInsight has released a new report titled

6 April 2026

Uncategorised

Spondylolisthesis Market Poised for Significant Growth Driven by Advanced Spinal Therapies, Rising Disease Burden, and Expanding Surgical Innovation Across Seven Major Countries

Spondylolisthesis Market Summary The Spondylolisthesis market is undergoing a significant transformation as heightened awareness, evolving clinical protocols, and next-generation spinal technologies converge to address a condition that affects millions worldwide. DelveInsight’s latest market analysis reveals that the spondylolisthesis treatment landscape is expanding

6 April 2026

Uncategorised

Celiac Disease Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

Celiac disease represents a growing global health concern, with current management limited to lifelong adherence to a gluten-free diet—an approach often associated with compliance challenges and reduced quality of life. The increasing prevalence of diagnosed cases and significant unmet clinical needs are

1 April 2026

Uncategorised

Spinocerebellar Ataxias Market: Emerging Therapies, Epidemiological Trends, and Pipeline Innovations Reshaping Neurological Care

Spinocerebellar Ataxia (SCA) is among the most complex and debilitating inherited neurological disorders, characterized by progressive cerebellar degeneration and a wide spectrum of neurological manifestations. As the scientific community deepens its understanding of this heterogeneous disease, the Spinocerebellar Ataxias market continues to

1 April 2026

Uncategorised

Soft Tissue Sarcoma With Lung Metastases Market: Epidemiology, Emerging Therapies, Pipeline Analysis, and Forecast Through 2036

Soft Tissue Sarcoma With Lung Metastasis Market and Epidemiology Analysis The Soft Tissue Sarcoma (STS) with lung metastases market is gaining increased attention from researchers, clinicians, and pharmaceutical developers as the unmet medical need in this indication remains critically high. Metastasis is

1 April 2026

Uncategorised

Soft Tissue Defect Market: Growth Trends, Epidemiology, Treatment Innovations, and Competitive Landscape Through 2034

Soft Tissue Defect Market Summary and Epidemiology Analysis The Soft Tissue Defect market is expected to strengthen as awareness of the disease increases, and more effective interventions are being developed. Rising incidences of traumatic injuries, chronic wounds, surgical complications, and congenital tissue

1 April 2026

Uncategorised

Smoking Cessation and Nicotine Addiction Market: Comprehensive Analysis of Epidemiology, Emerging Therapies, and Growth Opportunities Across Seven Major Markets Through 2034

Smoking Cessation and Nicotine Addiction Market Summary The Smoking Cessation and Nicotine Addiction market continues to evolve rapidly, driven by increasing awareness of tobacco-related health consequences, expanding pipeline therapies, and growing governmental and institutional support for cessation programs. According to the latest

1 April 2026

Uncategorised

Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

Eczema, a chronic inflammatory skin condition, significantly impacts patients’ quality of life through persistent itching and irritation. The market is being driven by growing awareness, increasing diagnosis rates, and the expanding availability of advanced therapies. The introduction of biologics and targeted treatments

30 March 2026

Uncategorised

Global Strategic Preparedness Drives Growth in Smallpox Market Amid Advancements in Vaccines, Antivirals, and Biodefense Initiatives

The global healthcare landscape continues to evolve with a renewed focus on preparedness against high-impact infectious diseases, even those eradicated decades ago. Among these, smallpox remains a critical priority due to its potential use in bioterrorism and the severe consequences of any

27 March 2026

Uncategorised

Advancing Therapeutic Innovations and Expanding Clinical Insights Drive Growth in Inflammatory Pain Market Landscape

The evolving landscape of the Inflammatory Pain market continues to attract significant attention from healthcare stakeholders, pharmaceutical innovators, and research institutions. With the rising burden of chronic inflammatory disorders worldwide, the demand for effective pain management strategies is accelerating. This press release

26 March 2026

Uncategorised - Page 11

Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) Market was approximately USD 3 billion in 2024, Estimates DelveInsight

Acute Kidney Injury Market: Epidemiology, Therapies, Companies, DelveInsight

Spondylolisthesis Market Poised for Significant Growth Driven by Advanced Spinal Therapies, Rising Disease Burden, and Expanding Surgical Innovation Across Seven Major Countries

Celiac Disease Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

Spinocerebellar Ataxias Market: Emerging Therapies, Epidemiological Trends, and Pipeline Innovations Reshaping Neurological Care

Soft Tissue Sarcoma With Lung Metastases Market: Epidemiology, Emerging Therapies, Pipeline Analysis, and Forecast Through 2036

Soft Tissue Defect Market: Growth Trends, Epidemiology, Treatment Innovations, and Competitive Landscape Through 2034

Smoking Cessation and Nicotine Addiction Market: Comprehensive Analysis of Epidemiology, Emerging Therapies, and Growth Opportunities Across Seven Major Markets Through 2034

Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

Global Strategic Preparedness Drives Growth in Smallpox Market Amid Advancements in Vaccines, Antivirals, and Biodefense Initiatives

Advancing Therapeutic Innovations and Expanding Clinical Insights Drive Growth in Inflammatory Pain Market Landscape

Recent Posts

Banner

Newsletter

Authors

pharmaglobenews

Michael Ashford

FDA Approves Otsuka’s VOYXACT (Sibeprenlimab-szsi): A Breakthrough in Primary Immunoglobulin A Nephropathy Treatment

Suggestions

Uncategorised - Page 11

Recent Posts

Banner

Newsletter

Authors